Your browser doesn't support javascript.
loading
[The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma].
Liu, J; He, H Y; Li, L; Lu, J; Qiang, W T; Guo, P; Hou, N; Jiang, H; Du, J; Fu, W J.
Afiliação
  • Liu J; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • He HY; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Li L; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Lu J; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Qiang WT; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Guo P; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Hou N; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Jiang H; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Du J; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
  • Fu WJ; Department of Hematology, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China.
Zhonghua Xue Ye Xue Za Zhi ; 42(1): 27-32, 2021 Jan 14.
Article em Zh | MEDLINE | ID: mdl-33677865

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China